TScan Therapeutics, Inc. ($TCRX)
Filing Information
| Accession Number | 0001193125-26-236870 |
|---|---|
| Form Type | 4 |
| Filing Date | May 22, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
134,000
Total Value
$0.00
P&L
+inf% (+$142,040.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Non- Qualified Stock Option (right to buy) | Derivative | May 20, 2026 | Grant/Award | 67,000 | $0.00 | $0.00 | 67,000 | Indirect | See Footnotes | View Details | |
Director | Non- Qualified Stock Option (right to buy) | Derivative | May 20, 2026 | Grant/Award | 67,000 | $0.00 | $0.00 | 67,000 | Indirect | See Footnotes | View Details |